samarium has been researched along with Ache in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.56) | 18.7374 |
| 1990's | 10 (27.78) | 18.2507 |
| 2000's | 14 (38.89) | 29.6817 |
| 2010's | 10 (27.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso-Coello, P; Martinez-Zapata, MJ; Roqué I Figuls, M; Scott-Brown, M | 2 |
| Kolesnikov-Gauthier, H; Lemoine, N; Olivier, A; Oudoux, A; Penel, N; Tresch-Bruneel, E | 1 |
| Chakraborty, S; Chakravarty, R; Dash, A; Goswami, D; Mohammed, SK; Sarma, HD | 1 |
| Gallicchio, R; Gattozzi, D; Giacomobono, S; Maddalena, F; Mainenti, P; Nardelli, A; Pellegrino, T; Simeon, V; Storto, G | 1 |
| Abruzzese, E; Di Maio, M; Iuliano, F; Trawinska, MM | 1 |
| Hiltunen, J; Sinzinger, H; Weiss, K | 1 |
| Allred, J; Ansell, SM; Buadi, F; Dingli, D; Dispenzieri, A; Elliott, MA; Gastineau, DA; Gertz, MA; Geyer, SM; Hayman, SR; Hogan, WJ; Inwards, DJ; Johnston, PB; Kumar, SK; Lacy, MQ; Laumann, KM; Litzow, MR; Micallef, IN; Porrata, L; Wiseman, GA | 1 |
| Abrahamsen, J; Jakobsen, M; Jønler, M; Lund, L; Petersen, LJ | 1 |
| Flux, GD; Hindorf, C; Ibisch, C; Kraeber Bodéré, F | 1 |
| O'Sullivan, JM; Parker, CC; Vengalil, S | 1 |
| D'angelo, G; Maini, CL; Mantini, G; Mariani, G; Salvatori, M; Sciuto, R; Sperduti, I | 1 |
| Douard, MC; George, B; Rain, JD | 1 |
| Fuster, D; Pons, F; Vidal-Sicart, S | 1 |
| Coleman, RE; Ell, PJ; Freeman, LM; Hoskin, PJ; Kotler, JA; Olivier, P; Quick, DP; Reid, RH; Sartor, O | 1 |
| Szefer, J; Zuchora, Z | 1 |
| Albritton, K; Anderson, PM; Dubansky, SA; Erlandson, L; Rodriguez, V; Trotz, B; Wiseman, GA | 1 |
| Antunes, P; Costa, J; Delgado, R; Gano, L; Lacerda, S; Lima, LM; Marques, F; Paula Campello, M; Santos, I | 1 |
| Chen, LX; Fan, W; Liu, XW; Tang, Q; Wang, GH; Zeng, ZY; Zhi, SF | 1 |
| Bushnell, DL; Ell, PJ; Quick, DP; Reid, RH; Sartor, O | 1 |
| Dolezal, J; Odrazka, K; Vizda, J | 1 |
| Franklin, S; Hillegonds, DJ; Shelton, DK; Vijayakumar, S; Vijayakumar, V | 1 |
| Bayouth, JE; Fossella, FV; Kasi, LP; Macey, DJ | 1 |
| Fordyce, WA; Fossella, FV; Goeckeler, WF; Kasi, LP; Price, DR; Stoneburner, LK | 1 |
| Alberts, AS; Kritzinger, V; Louw, WK; Nel, JS; Smit, BJ; van Beek, A; van Rensburg, AJ | 1 |
| Croft, S; Dormehl, I; Louw, WK; Milner, RJ | 1 |
| Coleman, RE | 1 |
| Alberts, AS; Louw, WK; van Rensburg, AJ | 1 |
| Papatheofanis, FJ | 1 |
| Bielack, S; Franzius, C; Jürgens, H; Schober, O; Sciuk, J; Vollet, B | 1 |
| Ford, PV; Murphy, PH | 1 |
| Serafini, AN | 1 |
| Budd, RS; Martin, JJ; Sandeman, TF | 1 |
| Claringbold, PG; Hetherington, EL; Martindale, AA; Sorby, P; Turner, JH | 1 |
| Ketring, AR | 1 |
11 review(s) available for samarium and Ache
| Article | Year |
|---|---|
WITHDRAWN: Radioisotopes for metastatic bone pain.
Topics: Bone Neoplasms; Fractures, Bone; Humans; Hypercalcemia; Pain; Pain Measurement; Phosphorus Radioisotopes; Radioisotopes; Randomized Controlled Trials as Topic; Ruthenium Radioisotopes; Samarium; Spinal Cord Compression; Strontium Radioisotopes | 2017 |
Clinical dosimetry in the treatment of bone tumors: old and new agents.
Topics: Bone Neoplasms; Humans; Pain; Palliative Care; Phosphorus Radioisotopes; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radium; Rhenium; Samarium; Strontium Radioisotopes; Tin Radioisotopes | 2011 |
Radioisotopes for metastatic bone pain.
Topics: Bone Neoplasms; Fractures, Bone; Humans; Hypercalcemia; Pain; Pain Measurement; Phosphorus Radioisotopes; Radioisotopes; Randomized Controlled Trials as Topic; Ruthenium Radioisotopes; Samarium; Spinal Cord Compression; Strontium Radioisotopes | 2011 |
Use of radionuclides in metastatic prostate cancer: pain relief and beyond.
Topics: Bone Neoplasms; Humans; Male; Men's Health; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radium; Rhenium; Samarium; Strontium | 2012 |
Targeted "bone-seeking" radiopharmaceuticals for palliative treatment of bone metastases: a systematic review and meta-analysis.
Topics: Bone Neoplasms; Comorbidity; Humans; Pain; Palliative Care; Radiation Injuries; Radiopharmaceuticals; Risk Factors; Samarium; Strontium Radioisotopes; Treatment Outcome | 2012 |
[Metabolic radiotherapy: what role will it have in 2001?].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Analgesics, Opioid; Bone Neoplasms; Clinical Trials as Topic; Double-Blind Method; Forecasting; France; Hematologic Diseases; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Phosphorus Radioisotopes; Prospective Studies; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Samarium; Strontium; Strontium Radioisotopes; Treatment Outcome | 2002 |
[Palliative treatment of metastasic bone pain].
Topics: Analgesia; Bone Neoplasms; Contraindications; Drug Costs; Forecasting; Humans; Pain; Palliative Care; Radioisotopes; Radiopharmaceuticals; Rhenium; Samarium; Strontium Radioisotopes; Tin Radioisotopes; Treatment Outcome | 2003 |
[Radionuclide therapy for painful bone metastases].
Topics: Bone Neoplasms; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Radioisotopes; Radiopharmaceuticals; Samarium; Strontium; Strontium Radioisotopes | 2004 |
The management of painful bone metastases with an emphasis on radionuclide therapy.
Topics: Bone Neoplasms; Combined Modality Therapy; Humans; Neoplasm Metastasis; Pain; Palliative Care; Radioisotopes; Rhenium; Samarium; Strontium Radioisotopes | 2007 |
How can we improve the treatment of bone metastases further?
Topics: Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Estrogen Antagonists; Female; Forecasting; Humans; Male; Multiple Myeloma; Osteolysis; Osteoporosis; Pain; Palliative Care; Prostatic Neoplasms; Quality of Life; Radioisotope Teletherapy; Randomized Controlled Trials as Topic; Samarium | 1998 |
Therapy of metastatic bone pain.
Topics: Analgesics; Animals; Bone Neoplasms; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Phosphates; Phosphorus Radioisotopes; Radioisotopes; Radiopharmaceuticals; Samarium; Strontium; Strontium Radioisotopes | 2001 |
4 trial(s) available for samarium and Ache
| Article | Year |
|---|---|
A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
Topics: Adult; Aged; Bone Marrow; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Organometallic Compounds; Organophosphorus Compounds; Pain; Peripheral Blood Stem Cell Transplantation; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Salvage Therapy; Samarium; Tissue Distribution; Transplantation Conditioning | 2010 |
Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Diseases; Bone Neoplasms; Double-Blind Method; Drug Combinations; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Pain Measurement; Prospective Studies; Prostatic Neoplasms; Radioisotopes; Samarium | 2004 |
Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases.
Topics: Bone and Bones; Bone Marrow; Bone Neoplasms; Chelating Agents; Humans; Organophosphorus Compounds; Pain; Palliative Care; Radioisotopes; Radionuclide Imaging; Radiotherapy Dosage; Samarium | 1994 |
Dose response relationship and multiple dose efficacy and toxicity of samarium-153-EDTMP in metastatic cancer to bone.
Topics: Bone Neoplasms; Dose-Response Relationship, Radiation; Humans; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Pain Management; Palliative Care; Radioisotopes; Radiotherapy Dosage; Samarium | 1997 |
21 other study(ies) available for samarium and Ache
| Article | Year |
|---|---|
Efficacy and safety of
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Humans; Male; Middle Aged; Pain; Radioisotopes; Retrospective Studies; Samarium; Treatment Outcome | 2018 |
Syntheses and evaluation of
Topics: Adsorption; Animals; Coordination Complexes; Diphosphonates; Drug Stability; Durapatite; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Ligands; Male; Muscle, Skeletal; Pain; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Wistar; Samarium; Tissue Distribution | 2018 |
Palliative treatment of bone metastases with samarium-153 EDTMP at onset of pain.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Female; Humans; Male; Middle Aged; Pain; Palliative Care; Samarium | 2014 |
153Sm: its use in multiple myeloma and report of a clinical experience.
Topics: Combined Modality Therapy; Diphosphonates; Humans; Isotopes; Multiple Myeloma; Organometallic Compounds; Organophosphorus Compounds; Pain; Radiography; Samarium | 2008 |
Background, reasons and benefits using the vienna protocol for the treatment of painful bone recurrences with 153Samarium-EDTMP.
Topics: Analgesics, Non-Narcotic; Bone Neoplasms; Humans; Neoplasm Recurrence, Local; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Samarium; Treatment Outcome | 2009 |
Samarium-153 treatment of bone pain in patients with metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Humans; Male; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radioisotopes; Samarium | 2010 |
Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma.
Topics: Adolescent; Adult; Alkaline Phosphatase; Analgesics, Non-Narcotic; Antigens, CD34; Bone and Bones; Bone Neoplasms; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Image Processing, Computer-Assisted; Neoplasm Metastasis; Organometallic Compounds; Organophosphorus Compounds; Osteosarcoma; Pain; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Remission Induction; Samarium; Sarcoma; Stem Cells; Time Factors | 2005 |
13- and 14-membered macrocyclic ligands containing methylcarboxylate or methylphosphonate pendant arms: chemical and biological evaluation of their (153)Sm and (166)Ho complexes as potential agents for therapy or bone pain palliation.
Topics: Animals; Bone and Bones; Carboxylic Acids; Female; Holmium; Lanthanoid Series Elements; Lanthanum; Ligands; Macrocyclic Compounds; Mice; Molecular Structure; Organophosphorus Compounds; Pain; Palliative Care; Radioisotopes; Samarium; Tissue Distribution | 2006 |
[Primary investigation of dose-effect relationship of 153Sm-EDTMP in treating multiple bone metastases].
Topics: Adult; Analgesics, Non-Narcotic; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Radiation; Female; Humans; Middle Aged; Monte Carlo Method; Nasopharyngeal Neoplasms; Organometallic Compounds; Organophosphorus Compounds; Pain; Pain Measurement; Radioisotopes; Samarium | 2006 |
Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Neoplasms; Breast Neoplasms; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Pain Measurement; Palliative Care; Prospective Studies; Prostatic Neoplasms; Safety; Samarium | 2007 |
Prospective evaluation of samarium-153-EDTMP radionuclide treatment for bone metastases in patients with hormone-refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Neoplasms; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Pain Measurement; Prospective Studies; Prostatic Neoplasms; Radionuclide Imaging; Samarium; Treatment Outcome | 2007 |
Analysis of urine samples from metastatic bone cancer patients administered 153Sm-EDTMP.
Topics: Bone Neoplasms; Chelating Agents; Chromatography, High Pressure Liquid; Humans; Organophosphorus Compounds; Pain; Radioisotopes; Samarium | 1993 |
Samarium-153 lexidronam for painful bone metastases.
Topics: Analgesics, Non-Narcotic; Bone Neoplasms; Clinical Trials as Topic; Costs and Cost Analysis; Dose-Response Relationship, Drug; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Radioisotopes; Samarium | 1997 |
Targeted radiotherapy with Sm-153-EDTMP in nine cases of canine primary bone tumours.
Topics: Age Factors; Analgesics, Non-Narcotic; Animals; Body Weight; Bone Neoplasms; Dog Diseases; Dogs; Female; Male; Organometallic Compounds; Organophosphorus Compounds; Osteosarcoma; Pain; Radiography, Thoracic; Radioisotopes; Samarium; Sex Factors; Treatment Outcome | 1998 |
Quantifying the radiation dosage to individual skeletal lesions treated with samarium-153-EDTMP.
Topics: Autoradiography; Bone Neoplasms; Gamma Cameras; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Phantoms, Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Samarium; Tissue Distribution; Tomography, Emission-Computed | 1998 |
Variation in oncologic opinion regarding management of metastatic bone pain with systemic radionuclide therapy.
Topics: Aged; Analgesics, Opioid; Attitude of Health Personnel; Bone Neoplasms; Data Collection; Female; Humans; Male; Medical Oncology; Middle Aged; Pain; Palliative Care; Radioisotopes; Samarium; Strontium Radioisotopes | 1999 |
High-activity samarium-153-EDTMP therapy in unresectable osteosarcoma.
Topics: Adult; Bone Neoplasms; Female; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Organometallic Compounds; Organophosphorus Compounds; Osteosarcoma; Pain; Palliative Care; Pelvic Neoplasms; Radioisotopes; Radionuclide Imaging; Samarium | 1999 |
Hemodialysis in a patient being treated with 153Sm.
Topics: Aged; Bone Neoplasms; Female; Hemodialysis Solutions; Humans; Pain; Palliative Care; Radioisotopes; Renal Dialysis; Samarium | 2001 |
Samarium-153-labelled EDTMP for bone metastases from cancer of the prostate.
Topics: Aged; Aged, 80 and over; Bone Marrow; Bone Neoplasms; Carcinoma; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiotherapy Dosage; Remission Induction; Samarium; Survival Rate; Thrombocytopenia | 1992 |
A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases.
Topics: Bone Neoplasms; Dose-Response Relationship, Radiation; Hematopoiesis; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Radioisotopes; Radiotherapy Dosage; Samarium | 1989 |
153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals.
Topics: Animals; Bone Neoplasms; Dogs; Etidronic Acid; Humans; Kinetics; Organophosphorus Compounds; Pain; Rabbits; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Technetium Tc 99m Medronate; Tissue Distribution | 1987 |